The global Minimally Invasive Surgical Instruments Market was estimated at USD 31,650.6 million in 2023 and is projected to reach USD 63,045.5 million by 2030, expanding at a CAGR of 10.3% from 2024 to 2030. The increasing acceptance of surgical robots, along with the clinical and economic advantages associated with minimally invasive procedures, is supporting this expansion. Compared with conventional open surgery, minimally invasive procedures can involve smaller incisions, reduced discomfort, shorter hospital stays, and faster recovery, increasing their adoption across multiple surgical applications.
What Is Driving the Shift Toward Minimally Invasive Surgical Instruments?
Why are hospitals and surgeons increasingly incorporating minimally invasive instruments into surgical workflows? The growing prevalence of chronic diseases, an aging population, increasing orthopedic procedures, and technological advancements are contributing to demand. Minimally invasive procedures require specialized instruments that can provide accuracy and control despite limited visibility and restricted ranges of motion. This has encouraged the development of endoscopic cameras, visualization systems, specialized instruments, catheters, monitoring devices, and robotic surgical systems.
The demand is also connected with the expansion of procedures across cardiac, orthopedic, ophthalmic, neurological, gastrointestinal, vascular, thoracic, gynecological, and urological applications. As surgical techniques become more sophisticated, instrument manufacturers are focusing on designs that improve portability, precision, visualization, and cost-effectiveness.
Download a free sample report or claim your copy of this full market intelligence report
Why Are Handheld Instruments Important to the Market?
What makes handheld instruments such an important part of the minimally invasive surgical instruments market? The handheld instruments segment accounted for a revenue share of 22.1% in 2023. These instruments can provide surgeons with easier access during procedures while supporting instrument triangulation and helping limit damage to surrounding tissues. Their use across different minimally invasive procedures has supported continued demand.
Most minimally invasive handheld instruments are single-use products, which further contributes to their utilization across surgical settings. Product development is also creating new opportunities within this segment. For example, in September 2022, Zimmer Biomet announced an agreement with Associates of Surgical Planning to commercialize its FDA-approved mixed reality navigation system for hip replacement.
How Are Hospitals and Ambulatory Surgical Centers Shaping Demand?
Why does the healthcare setting matter for market expansion? Hospitals accounted for the largest end-use share, representing 68.8% of revenue in 2023. The segment is supported by the increasing prevalence of chronic disorders among older populations and the resulting need for surgical treatment. Hospitals also provide the infrastructure required for advanced visualization systems, specialized instruments, and robotic-assisted procedures.
At the same time, ambulatory surgical centers are becoming an important growth area. Their ability to support procedures outside traditional inpatient settings, combined with reimbursement availability for ambulatory surgical procedures in the U.S., is supporting demand. The expansion of ASCs therefore adds another channel for minimally invasive surgical instruments beyond conventional hospital environments.
Which Surgical Applications Are Creating the Strongest Demand?
Where are minimally invasive instruments being used most extensively? Orthopedics represented the largest application segment in 2023, accounting for 23.6% of revenue. Knee and hip replacement procedures are important contributors because minimally invasive approaches can support procedures with smaller incisions and shorter hospitalization periods.
The broader application landscape is also expanding. Cardiac, gastrointestinal, dental, cosmetic, vascular, thoracic, gynecological, and urological procedures all use minimally invasive techniques. Increasing incidence of conditions requiring orthopedic and gastrointestinal interventions is therefore creating demand for specialized instruments across multiple surgical categories.
How Is Technology Changing the Minimally Invasive Surgical Instruments Market?
Can technological development change what surgeons can accomplish through minimally invasive techniques? Continuous innovation is playing a major role in the market. Improved product designs are intended to provide greater accuracy and control while supporting patient safety. Surgical robots have become particularly important because they combine specialized instruments with enhanced visualization and controlled movement.
New product launches and approvals are also expanding the range of procedures that can be performed using minimally invasive approaches. For example, Abbott launched Navitor, an advanced transcatheter aortic valve implantation system, in December 2022. Abbott also launched minimally invasive heart valve-related devices in India, demonstrating the continued expansion of minimally invasive technologies into cardiovascular procedures.
What Role Does Regional Healthcare Development Play?
Why is regional healthcare infrastructure important to future market expansion? North America accounted for 29.9% of the global market in 2023, supported by established healthcare infrastructure, favorable reimbursement policies, and the high prevalence of chronic diseases. The region also benefits from the presence of healthcare companies and advanced surgical technologies.
Asia Pacific, meanwhile, is expected to record the fastest CAGR of 10.8% from 2024 to 2030. Improving healthcare infrastructure, government initiatives, and economic development in countries such as India and Japan are supporting regional expansion. The presence of large populations seeking affordable treatment options is also creating opportunities for minimally invasive procedures and associated instruments.
What Could Shape the Market Through 2030?
How will the market evolve as surgical techniques continue to advance? The increasing adoption of minimally invasive procedures, continued product launches, expanding applications, and technological developments are expected to remain important factors. The ability to perform increasingly complex procedures through minimally invasive approaches is also broadening the potential application base.
At the same time, specialized instruments and support systems require skilled surgical teams and sophisticated healthcare infrastructure. This means that future adoption will depend not only on instrument innovation but also on the availability of trained professionals, appropriate facilities, and supporting technologies.
The combination of surgical innovation, increasing procedure volumes, and expanding healthcare infrastructure is therefore creating a broader ecosystem for minimally invasive surgical instruments. With the market projected to reach USD 63,045.5 million by 2030, developments across devices, applications, healthcare settings, and regions are expected to remain central to the industry's evolution.
About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.